Evidence map›Paper›PMID 35139242›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Reversibly Photoswitching Upconversion Nanoparticles for Super-Sensitive Photoacoustic Molecular Imaging.

Cheng Liu, Xianchuang Zheng, Tingting Dai, Huiliang Wang, Xian Chen, Bing Chen, Tianying Sun, Feng Wang, Steven Chu, Jianghong Rao

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Recent Progress in Synthesis ofNuclear medicine and molecular imaging · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Bioimaging with Upconversion Nanoparticles.Advanced photonics research · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cheng LiuMolecular Imaging Program at Stanford, Departments of Radiology and Chemistry, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Xianchuang ZhengMolecular Imaging Program at Stanford, Departments of Radiology and Chemistry, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Tingting DaiMolecular Imaging Program at Stanford, Departments of Radiology and Chemistry, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Huiliang WangDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Xian ChenDepartment of Materials Science and Engineering, City University of Hong Kong, Hong Kong SAR, China.
Bing ChenDepartment of Materials Science and Engineering, City University of Hong Kong, Hong Kong SAR, China.
Tianying SunDepartment of Materials Science and Engineering, City University of Hong Kong, Hong Kong SAR, China.
Feng WangDepartment of Materials Science and Engineering, City University of Hong Kong, Hong Kong SAR, China.
Steven ChuDepartments of Physics and Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305, USA.
Jianghong RaoMolecular Imaging Program at Stanford, Departments of Radiology and Chemistry, School of Medicine, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-5143-9529

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Nano Characterization and Nano Fabrication CoreU54CA199075 · NCI · STANFORD UNIVERSITY · PI WANG, SHAN X. · 2015 to 2019
$9.6M
Noninvasive deep-tissue single-cell imaging and nanoprobe developmentR01GM128089 · NIGMS · STANFORD UNIVERSITY · PI CHU, STEVEN, RAO, JIANGHONG · 2018 to 2021
$2.2M
NCI NIH HHS P30 CA124435NCI NIH HHS U54 CA199075NIGMS NIH HHS R01 GM128089
6 · The paper itself

Abstract

Photoacoustic (PA) imaging uses light excitation to generate the acoustic signal for detection and improves tissue penetration depth and spatial resolution in the clinically relevant depth of living subjects. However, strong background signals from blood and pigments have significantly compromised the sensitivity of PA imaging with exogenous contrast agents. Here we report a nanoparticle-based probe design that uses light to reversibly modulate the PA emission to enable photoacoustic photoswitching imaging (PAPSI) in living mice. Such a nanoprobe is built with upconverting nanocrystals and photoswitchable small molecules and can be switched on by NIR light through upconversion to UV energy. Reversibly photoswitching of the nanoprobe reliably removed strong tissue background, increased the contrast-to-noise ratio, and thus improved imaging sensitivity. We have shown that PAPSI can image 0.05 nM of the nanoprobe in hemoglobin solutions and 10

Indexed as

NanoparticlesPhotoacoustic TechniquesAcousticsAnimalsHumansMiceMolecular ImagingSpectrum AnalysisImaging AgentsNear-infraredPhotoacoustic ImagingReversible PhotoswitchingUpconversion Nanoparticles

Identifiers

PMID35139242
PMCPMC9038665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.